Universal Hepatitis B Vaccination in Adults Aged 19–59 Years: Updated Recommendations of the Advisory Committee on Immunization Practices — United States, 2022
Mark K. Weng
1, 2, 3, 4, 5
,
Mona Doshani
1, 2, 3, 4, 5
,
Mohammed A. Khan
1, 2, 3, 4, 5
,
Sharon Frey
1, 2, 3, 4, 5
,
Kevin A. Ault
1, 2, 3, 4, 5
,
Kelly L Moore
1, 2, 3, 4, 5
,
Eric W. Hall
1, 2, 3, 4, 5
,
Rebecca L. Morgan
1, 2, 3, 4, 5
,
Doug Campos-Outcalt
1, 2, 3, 4, 5
,
C. Wester
1, 2, 3, 4, 5
,
Noele P. Nelson
1, 2, 3, 4, 5
1
Center for Surveillance, Epidemiology, and Laboratory
2
Health Science and Surveillance
3
Human Services, Atlanta, GA 30329-4027.
|
4
Information Technology
5
Visual Information Specialist
Publication type: Journal Article
Publication date: 2022-04-01
scimago Q1
wos Q1
SJR: 9.559
CiteScore: 39.4
Impact factor: 17.3
ISSN: 01492195, 1545861X
PubMed ID:
35358162
General Medicine
Health, Toxicology and Mutagenesis
Epidemiology
Health (social science)
Health Information Management
Abstract
Hepatitis B (HepB) vaccines have demonstrated safety, immunogenicity, and efficacy during the past 4 decades (1,2).However, vaccination coverage among adults has been suboptimal, limiting further reduction in hepatitis B virus (HBV) infections in the United States.This Advisory Committee on Immunization Practices (ACIP) recommendation expands the indicated age range for universal HepB vaccination to now include adults aged 19-59 years.Removing the risk factor assessment previously recommended to determine vaccine eligibility in this adult age group (2) could increase vaccination coverage and decrease hepatitis B cases.
Found
Nothing found, try to update filter.
Found
Nothing found, try to update filter.
Top-30
Journals
|
1
2
3
4
5
6
7
8
|
|
|
Vaccine
8 publications, 5.71%
|
|
|
Open Forum Infectious Diseases
7 publications, 5%
|
|
|
Vaccines
6 publications, 4.29%
|
|
|
Human Vaccines and Immunotherapeutics
5 publications, 3.57%
|
|
|
Expert Review of Vaccines
5 publications, 3.57%
|
|
|
Morbidity and Mortality Weekly Report
4 publications, 2.86%
|
|
|
Annals of Internal Medicine
3 publications, 2.14%
|
|
|
Infectious Disease Clinics of North America
3 publications, 2.14%
|
|
|
Journal of Viral Hepatitis
3 publications, 2.14%
|
|
|
Current Hepatology Reports
3 publications, 2.14%
|
|
|
Clinical Gastroenterology and Hepatology
2 publications, 1.43%
|
|
|
Public Health Reports
2 publications, 1.43%
|
|
|
Diabetes Care
2 publications, 1.43%
|
|
|
Journal of Community Health
2 publications, 1.43%
|
|
|
The Lancet Public Health
2 publications, 1.43%
|
|
|
Gastro Hep Advances
2 publications, 1.43%
|
|
|
JAMA - Journal of the American Medical Association
2 publications, 1.43%
|
|
|
BMC Public Health
2 publications, 1.43%
|
|
|
Therapeutic Advances in Infectious Disease
2 publications, 1.43%
|
|
|
Canadian Liver Journal
2 publications, 1.43%
|
|
|
New England Journal of Medicine
1 publication, 0.71%
|
|
|
Annals of Pharmacotherapy
1 publication, 0.71%
|
|
|
Frontiers in Pediatrics
1 publication, 0.71%
|
|
|
Sports Medicine - Open
1 publication, 0.71%
|
|
|
Hepatology Communications
1 publication, 0.71%
|
|
|
Journal of Forensic Nursing
1 publication, 0.71%
|
|
|
Obstetrics and Gynecology Clinics of North America
1 publication, 0.71%
|
|
|
The Lancet Regional Health - Western Pacific
1 publication, 0.71%
|
|
|
Primary Care - Clinics in Office Practice
1 publication, 0.71%
|
|
|
1
2
3
4
5
6
7
8
|
Publishers
|
5
10
15
20
25
30
35
40
|
|
|
Elsevier
36 publications, 25.71%
|
|
|
Springer Nature
19 publications, 13.57%
|
|
|
Taylor & Francis
14 publications, 10%
|
|
|
MDPI
11 publications, 7.86%
|
|
|
Oxford University Press
10 publications, 7.14%
|
|
|
Wiley
9 publications, 6.43%
|
|
|
Ovid Technologies (Wolters Kluwer Health)
8 publications, 5.71%
|
|
|
SAGE
5 publications, 3.57%
|
|
|
Centers for Disease Control MMWR Office
4 publications, 2.86%
|
|
|
American College of Physicians
3 publications, 2.14%
|
|
|
Frontiers Media S.A.
2 publications, 1.43%
|
|
|
BMJ
2 publications, 1.43%
|
|
|
American Diabetes Association
2 publications, 1.43%
|
|
|
American Society of Clinical Oncology (ASCO)
2 publications, 1.43%
|
|
|
American Medical Association (AMA)
2 publications, 1.43%
|
|
|
University of Toronto Press Inc. (UTPress)
2 publications, 1.43%
|
|
|
Massachusetts Medical Society
1 publication, 0.71%
|
|
|
Association of Military Surgeons of the US
1 publication, 0.71%
|
|
|
Public Library of Science (PLoS)
1 publication, 0.71%
|
|
|
IntechOpen
1 publication, 0.71%
|
|
|
Centers for Disease Control and Prevention (CDC)
1 publication, 0.71%
|
|
|
Cambridge University Press
1 publication, 0.71%
|
|
|
Edizioni Minerva Medica
1 publication, 0.71%
|
|
|
5
10
15
20
25
30
35
40
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.
Are you a researcher?
Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
140
Total citations:
140
Citations from 2024:
94
(67.15%)
Cite this
GOST |
RIS |
BibTex |
MLA
Cite this
GOST
Copy
Weng M. K. et al. Universal Hepatitis B Vaccination in Adults Aged 19–59 Years: Updated Recommendations of the Advisory Committee on Immunization Practices — United States, 2022 // Morbidity and Mortality Weekly Report. 2022. Vol. 71. No. 13. pp. 477-483.
GOST all authors (up to 50)
Copy
Weng M. K. et al. Universal Hepatitis B Vaccination in Adults Aged 19–59 Years: Updated Recommendations of the Advisory Committee on Immunization Practices — United States, 2022 // Morbidity and Mortality Weekly Report. 2022. Vol. 71. No. 13. pp. 477-483.
Cite this
RIS
Copy
TY - JOUR
DO - 10.15585/mmwr.mm7113a1
UR - http://www.cdc.gov/mmwr/volumes/71/wr/mm7113a1.htm?s_cid=mm7113a1_w
TI - Universal Hepatitis B Vaccination in Adults Aged 19–59 Years: Updated Recommendations of the Advisory Committee on Immunization Practices — United States, 2022
T2 - Morbidity and Mortality Weekly Report
AU - Weng, Mark K.
AU - Doshani, Mona
AU - Khan, Mohammed A.
AU - Frey, Sharon
AU - Ault, Kevin A.
AU - Moore, Kelly L
AU - Hall, Eric W.
AU - Morgan, Rebecca L.
AU - Campos-Outcalt, Doug
AU - Wester, C.
AU - Nelson, Noele P.
PY - 2022
DA - 2022/04/01
PB - Centers for Disease Control MMWR Office
SP - 477-483
IS - 13
VL - 71
PMID - 35358162
SN - 0149-2195
SN - 1545-861X
ER -
Cite this
BibTex (up to 50 authors)
Copy
@article{2022_Weng,
author = {Mark K. Weng and Mona Doshani and Mohammed A. Khan and Sharon Frey and Kevin A. Ault and Kelly L Moore and Eric W. Hall and Rebecca L. Morgan and Doug Campos-Outcalt and C. Wester and Noele P. Nelson and others},
title = {Universal Hepatitis B Vaccination in Adults Aged 19–59 Years: Updated Recommendations of the Advisory Committee on Immunization Practices — United States, 2022},
journal = {Morbidity and Mortality Weekly Report},
year = {2022},
volume = {71},
publisher = {Centers for Disease Control MMWR Office},
month = {apr},
url = {http://www.cdc.gov/mmwr/volumes/71/wr/mm7113a1.htm?s_cid=mm7113a1_w},
number = {13},
pages = {477--483},
doi = {10.15585/mmwr.mm7113a1}
}
Cite this
MLA
Copy
Weng, Mark K., et al. “Universal Hepatitis B Vaccination in Adults Aged 19–59 Years: Updated Recommendations of the Advisory Committee on Immunization Practices — United States, 2022.” Morbidity and Mortality Weekly Report, vol. 71, no. 13, Apr. 2022, pp. 477-483. http://www.cdc.gov/mmwr/volumes/71/wr/mm7113a1.htm?s_cid=mm7113a1_w.
Profiles